Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BROKE!
It's a sham folks!!!
Banyan gets FDA approval while JJ presents at biology conferences...
https://www.nytimes.com/2018/02/14/health/concussion-fda-bloodtest.html
ITS A SHAM FOLKS!
With the de-listing fears at least temporarily on-hold and the announced upcoming investor conference, I would not be surprised to see AEMD trade around the $1.10 offering price. GLTA
Dilution finalized...and it's bad.
https://www.streetinsider.com/Corporate+News/Aethlon+Medical+%28AEMD%29+Prices+5.45M+Share+Offering+at+%241.10Sh/13346952.html
The stock will ping to $1.10 very quickly on this news and go much lower once the de-listing is announced, on it's way to zero in the not-to-distant future. GLTA
No anger at all...I rest well at night knowing my money is invested wisely. In an 8 year+ bull market, where you could pretty much throw darts and make money, why would you invest in a company banking on some very low probability events (such as an outbreak)? If you can't see the writing on the wall on this one, I truly feel sorry for you. GLTA
Not sure what "obfuscating" means but it sounds ugly...
The obvious thing that's going on here is that the stock is going to zero. GLTA
Brilliant indeed...
And you asked about why I predicted more dilution was coming? SEC filing this morning should answer your question:
http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=12284008&RcvdDate=9/18/2017&CoName=AETHLON%20MEDICAL%20INC&FormType=S-1/A&View=html
Hate to say "I told you so"...
1) I strongly disagree. Delisting from the Nasdaq, which still looks imminent, is a severe blow to an already flatlining company. The funds are just simply drying up at 17 years.
2) You are correct - I know that a reverse split does not cause dilution. But tapping into the ATM funds and selling additional shares DOES. I suspect YOU know this.
3)The reality is Aethlon met the criteria for EAP, mainly on the "no current solution for these conditions" front. Doesnt imply approval. More importantly, it does not imply any demand for the product nor revenue. Nor a timeframe.
4) See above.
Agreed it's good news for the company. But it has to be taken in context. The stock performance after the initial spike speaks volumes. The smart money continues to sell this bump. And the tiny research grant announced this morning is doing nothing to help prop the stock...GLTA
Good news for Aethlon!
However, it's important to note the following:
1) even after today's bump, AEMD is nowhere close to satisfying their listing requirements on the Nasdaq
2) History tells us that JJ will use this event as another opportunity to sell more dillutive shares and potentially implement another reverse split
3) They are still no closer to actually having revenue
4) This event only give Aethlon a potentially faster opportunity to achieve FDA approval, NOT a inference or especially a guarantee that FDA approval will even happen. After 16 years, I'm guessing no...
Hope you sold the bump today and GLTA....
People finally wised up and hopefully saved alot of money...
They filed an S-1 on July 31st with a strange, open-ended offering and no share price for any of the shares. I suppose this is a stall tactic but JJ seems to be breaking new ground here on the SEC manipulation front...My best guess here is that the new S-1 shares will be traded on a new exchange as I believe de-listing is imminent. Maybe someone else has an explanation?
Either way, not a good sign at all for equity holders of this security.
13 Days ago...
I recommended FSLR stock at $43.81. The stock is now at $50.14 in pre-market after crushing earnings. A 14% gain in 13 days isn't bad but I am now adding to my FSLR position and will continue to add over the next 12 months. This one is just beginning.
One year target...$100. GLTA
ALL,
As a relief from the monotony of the AEMD discussions, on August 8th, 2016 I published my post entitled "PICKS" in which I suggested three stocks to BUY. Here are the results of those picks less than one year later:
Price on 8/8/16 Price Today Gain
MCHP $55.45 $80.84 +46% sell
AAPL $106.91 $149.04 +39% sell
FSLR $43.81 $42.94 -2% BUY
OK. I was a little early on FSLR. I will sell MCHP and AAPL now and BUY FSLR with the proceeds, as I believe FSLR is just beginning a multi-year megacycle that will deliver HUGE gains in the next 24-36 months. Check back in a year. Good luck to all...
AEMD longtimers...
I know this breaks the blog rules but...
I have been correct as I warned you about AEMD for years. I also told you about this alternate stock a year ago (and also included AAPL and MCHP) but here is is again:
FSLR is just beginning on a multiyear mega-cycle that will see the stock triple in just a few years IMO. Get in now and you will recoup your "investment" in AEMD...they'll be talking about this one many years from now and about how many millionaires it made...GLTA
Come on, Jim...You know you want to use the 4th as a means to slide another round of financing in under the radar...Post it this morning before the market closes and nobody will ever notice!!
What do you make of it Conix? I think my reply will be "for a "normal" stock, yes, but for AEMD....
Strongest SELL
Its rare to see the CEO of a company present such a HORRIBLE result from a safety study as Jim Joyce did yesterday for Aethlon Medical. A "manufacturing problem" caused the long delays in finishing the study? A manufacturing problem for 10 units, Jim? Really? And you're optimistic that the US government is going to "stockpile" your product? How long will it take to stockpile 10 units? 20 units? Thousands? It took you many months just to make 10 pcs...Not to mention that after 15 years you have NO DATA on the shelf life of your product for a "stockpile", nor are your FDA approved, nor have you ever presented data that proves capturing x copies of a virus makes one bit of difference in a patients recovery. You capture thousands and millions of copies but unfortunately there are billions in a patient.
This was your one ongoing FDA study and there was a MAJOR "protocol error" in how the tests were handled? Really? So the virus capture numbers really cannot be trusted AT ALL, nor can the rest of the results. The US government will NEVER stockpile your product, Jim, because you and your company are a JOKE. And if the market correctly prices equities, the share price of AEMD will soon be exactly what it is worth - zero.
Here's how this really works...
In March, Empery Asset Management bought 575,000 shares of AEMD from the company in a private placement for $3.50. At the time, the stock was trading around $3.85 or so (which at the time upset current shareholders because the stock was sold at an obvious discount). Today the stock trades at $2.26.
Anyone who has followed AEMD closely over the years (or followed other small/penny stocks who use the same scheme) know that without a doubt, EMPERY IS GOING TO MAKE VERY GOOD MONEY ON THEIR INVESTMENT, WITHIN A FEW MONTHS TIME. Just go back and research the Roth placements. same pattern - Roth bought at a slight discount to market, a few weeks or months later some "new" news is released and the stock price and volume pops, giving Roth all the liquidity they need to exit with 50%, 100%, 200% profits.
You see, Empery didn't make an investment in AEMD on the same information you or I are using to make a decision; they invested because they already know the news that will be announced on June 21st is GOOD NEWS. The stock is going to pop to somewhere above $4 and Empery will exit with their money, expediting the corresponding fall of the stock in the following few days.
People who bought on the news (the average Joes) are left with way over-priced shares and a stock price dropping like a rock for no apparent reason. Sound familiar? To win, you have to beat them at their own game and buy in advance of the coming run-up.
Just my humble opinion - I could be wrong. GLTA
Critical update!
This is the start of the push I have been looking for since early May.
Check my post from 5/3 - I put on a 'strong buy' and predicted AEMD would be $3.75 by July 1st. That prediction is still in tact. GLTA
Watch for Reverse split announcement and filing around the holiday weekend, either Friday at the close of business or Tuesday. JJ is a creature of habit and sadly his pink-sheet tricks are still being used in full force...
With respect, I have doubts about your assertion that the patent will prevent anyone else from capturing exosomes in the diagnosis and treatment of cancer. As I read it, the patent protects Aethlon's specific METHOD OF CAPTURE of exosomes, not the entire exosome field in oncology. And there are MANY methods of exosome capture (and have been for over 30 years)...
So why would anyone license Aethlon's specific method of capture?
Could be...
I suspect JJ has another surprise or two up his sleeve short term but I'm not betting the mortgage money on it, that's for sure...Time will tell.
New Call on AEMD:
$3.75 by July 1st. GLTA
The Powassan Virus is the type that the HP captures:
http://www.today.com/health/worse-lyme-tick-borne-powassan-virus-worries-experts-t110892
Yes, no doubt about it now.
The target short term in between $3.50 and $4.00 per share. Still a nice return even from here...GLTA
Based on trade sizes and cadence today I speculate institutional buyers are coming in bargain hunting...
I was correct about the reason for the recent decline...
I suspected that an institutional investor sold due to pre-determined risk rails on the stock price. Cordasco sold completely out of 200K+ shares of AEMD...while Vanguard, UBS and Creative planning added smaller positions.
My short term trade thesis is still in tact...
Not "pumping anything...Just supporting my thesis that there may be (for the risk tolerant) a short-term trade opportunity here that could (COULD) take the stock back up towards $4, offering a nice return. This thesis is based on:
1) Watching the stock action for many years, specifically the action around new placements.
2) Short interest is very high setting up for potential squeeze
3) The drop in the last few weeks has happened on really very little substantive news
I'm right often but not always...GLTA
DARPA
I'm not so sure that DARPA/Military contracts are off the table at this point. From October article:
"Aethlon continues to operate under a systems integrator contract that was also awarded under the DARPA DLT program and the Company further disclosed that it has responded to two new U.S. Department of Defense (DOD) contract solicitation opportunities. A goal of the DLT program has been to develop a portable device that removes "dirty" blood from the body, separates harmful agents, and returns "clean" blood to the body in a manner similar to dialysis treatment of kidney failure. The resulting device could decrease the morbidity and mortality of sepsis, thereby saving thousands of lives and billions of dollars in the United States annually."
I believe expectations were overblown for an immediate contract extension on DARPA during 2016, especially considering 1) the length of time that military contracts take to get completed and 2) the surprise win of Trump and the corresponding shake-ups in the the DD. Longs could be pleasantly surprised...
I new DARPA/DD contract could bounce the stock back up into the $5 range easy IMO. Just speculation...GLTA
All difficult questions to answer...
1. I admire your fight but I would have no interest in attempting a hostile takeover of AEMD. Anything is possible but with institutional ownership below 5%, very large insider ownership and many 1000's of other smaller shareholders, putting together a plan/offer and presenting it would more than likely be a loss cause. I am not familiar enough to comment on whether the board has "poison pill" type measures in place. Takeovers are not my area of expertise, however.
2. I have to admit I am also a little surprised at the recent rate of decline on no major news. I suspect an institutional investor's tolerance for risk (with a potential delisting looming) caused them to exit. With the latest placement the company is actually well funded for the time being and in no risk of insolvency...
3. Honestly, your guess is probably as good as mine on the future of this company. I think the most likely scenario is more of the same. As far as the stock, the critical tell tale sign will be the $3.50 level from the last placement. For long-ballers, there is still the same chance for a homerun that there always was, as nothing as fundamentally changed in the last few weeks that I can see. The longs definitely need something soon though...
Something like that. It's very hard to even calculate that these days...
Some hope for the longs...
Aethlon stock pegged to $3.50 (albeit temporarily) after the latest placement at $3.50 was announced (when the stock was just below $4).
For the risk tolerant, I now believe (based on a long history of following the stock) there is a very good chance that the stock will soon trade at or above this $3.50 level - more than likely within the next month - offering some very good short-term returns. It will be a volatile ride...
GLTA
Ah yes, but oh so painfully right...well, painful for some.
When you're constantly attacked, made fun of, given the moniker "SH" from the other members of the board because you provide inconvenient yet highly accurate predictions that do not fit with THEIR OWN PERSONAL DESIRES...you tend to be a little less of a gentleman. What do they say -
"those who give respect, get respect" I think...
I feel for those who have lost on this stock. But to the haters - I take great joy in the fact that you could have made or saved a BOATLOAD of money had you listened to my very well researched and thought-out predictions...had you only not put your energy into attacking me and dismissing my inputs because they didn't jive with your position.
More predictions coming shortly...
GLTA
Looks like ol' SH was right again...
BREAKING: Cure for SEPSIS Found!?
http://www.wkyc.com/news/health/evms-doctor-believes-he-found-sepsis-cure/425790188
Short interest continues to increase in AEMD with potential for delisting:
http://www.nasdaq.com/symbol/aemd/short-interest